-
A survey of current and former egg donors revealed some possible gaps when it comes to communicating potential long-term risks.
-
Adolescents and their parents are interested in taking the COVID-19 vaccine; more education and other developments could sway even more, according to the results of a survey. Respondents indicated more information on safety and efficacy for adolescents was one of the top factors that would increase the likelihood of taking the vaccine. They also said primary care providers and health officials were their most trusted sources for vaccine information.
-
Parental rights issues often are asserted, but at the same time, society has a stake in protecting children from harm, including medical neglect.
-
Beyond the ethical questions, there are logistics, privacy, and even equity concerns to consider.
-
Interest in clinical research on cannabis and psilocybin is soaring. However, current barriers to studying these controlled substances raise ethical questions.
-
Differences in outcomes and responses to treatment in diverse populations often have been attributed to biological factors. However, standardized treatment can tell a divergent story, one in which parameters, such as geographic location and financial status, play a significant role in how a person responds. This underscores the importance of a diverse study population in clinical trials, researchers say.
-
In an updated policy statement, the American Society for Reproductive Medicine says transgender status should not prevent a patient from accessing fertility preservation. Further, reproductive services should be offered to all interested transgender or nonbinary individuals, barring other disqualifying factors (based on empirical evidence as opposed to bias or stereotypes).
-
A shorter program could be more useful for smaller universities that may not have the resources available to implement a longer program.
-
By including ordinary people, researchers could create consent forms, and a consenting process, that is primarily suited to meeting the needs of potential participants.
-
Keep in mind the person who has who to digest informed consent information. Avoiding complex terminology could lead to better understanding among the laypeople who participate in clinical trials.